Charming Medical MCTA
$29.36 +$0.00 (0.00%)
Market closed · Nov 5, 8:00 pm ET
Open$0.00
Prev close$29.36
Day range$0.00 – $0.00
Volume0.00
Market cap$445.55M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: ANNUAL, ended Mar 2026
Revenue$4.81M-22.7% YoY
Operating profit$128,873.00-92.0% YoY
Net profit-$22,648.00-101.9% YoY
Diluted EPS$0.00-100.0% YoY
Annual revenue
Profitability & balance sheet
Gross margin62.6%
Operating margin2.7%
Net margin-0.5%
Return on equity-0.9%
Return on assets-0.3%
Return on invested capital-1.9%
Current ratio1.89
Liabilities / assets47.5%
Cash & investments$6.54M
Total debt$541,356.00
Net cash (debt)$6.00M
Balance sheet
| Line item | 2026 Q4 | 2026 ANNUAL | 2026 Q2 | 2025 Q4 | 2025 ANNUAL |
|---|---|---|---|---|---|
| Total Non-Current Assets | $1.69M | $1.69M | $2.53M | $1.99M | $1.99M |
| Net PPE | $1.33M | $1.33M | $844,063.00 | $1.21M | $1.21M |
| -Gross PPE | $2.55M | $2.55M | $2.38M | $3.21M | $3.21M |
| -Accumulated Depreciation | -$1.22M | -$1.22M | -$1.54M | -$2.00M | -$2.00M |
| Non-Current Prepaid Assets | $354,019.00 | $354,019.00 | $170,544.00 | $128,290.00 | $128,290.00 |
| Non-Current Deferred Assets | $9,031.00 | $9,031.00 | $1.51M | $649,645.00 | $649,645.00 |
| Total Liabilities | $4.69M | $4.69M | $5.10M | $5.31M | $5.31M |
| Total Current Liabilities | $4.33M | $4.33M | $4.99M | $4.95M | $4.95M |
| Payables | $367,821.00 | $367,821.00 | $597,532.00 | $476,124.00 | $476,124.00 |
| -Accounts Payable | $17,200.00 | $17,200.00 | $0.00 | $3,480.00 | $3,480.00 |
| -Total Tax Payable | $307,368.00 | $307,368.00 | $221,374.00 | $221,339.00 | $221,339.00 |
| -Due to Related Parties Current | $9,435.00 | $9,435.00 | $367,682.00 | $214,603.00 | $214,603.00 |
| Inventory | $25,623.00 | $25,623.00 | $39,977.00 | $26,797.00 | $26,797.00 |
| -Other Receivables | $1.41M | $1.41M | $60,781.00 | $183,190.00 | $183,190.00 |
| Total Assets | $9.87M | $9.87M | $5.45M | $5.36M | $5.36M |
| Total Current Assets | $8.17M | $8.17M | $2.93M | $3.37M | $3.37M |
| Cash and Cash Equivalents & Short-Term Investments | $6.54M | $6.54M | $2.69M | $2.76M | $2.76M |
| -Cash and Cash Equivalents | $4.70M | $4.70M | $1.77M | $816,771.00 | $816,771.00 |
| -Short Term Investments | $1.84M | $1.84M | $912,233.00 | $1.94M | $1.94M |
| Receivables | $1.61M | $1.61M | $200,448.00 | $579,091.00 | $579,091.00 |
| -Accounts Receivable | $201,477.00 | $201,477.00 | $139,667.00 | $395,901.00 | $395,901.00 |
| -Other Payable | $33,818.00 | $33,818.00 | $8,476.00 | $36,702.00 | $36,702.00 |
| Current Accrued Expenses | $364,284.00 | $364,284.00 | $208,188.00 | $206,282.00 | $206,282.00 |
| Gains/Losses Not Affecting Retained Earnings | -$14,790.00 | -$14,790.00 | -$2,905.00 | -$3,569.00 | -$3,569.00 |
| Retained Earnings | $96,793.00 | $96,793.00 | $46,463.00 | $119,441.00 | $119,441.00 |
| Short-Term Debt and Capital Lease Obligation | $552,459.00 | $552,459.00 | $467,079.00 | $802,606.00 | $802,606.00 |
| -Current Debt | $185,799.00 | $185,799.00 | $246,812.00 | $314,226.00 | $314,226.00 |
| -Current Capital Lease Obligation | $366,660.00 | $366,660.00 | $220,267.00 | $488,380.00 | $488,380.00 |
| Current Deferred Liabilities | $3.05M | $3.05M | $3.72M | $3.46M | $3.46M |
| Total Non-Current Liabilities | $355,557.00 | $355,557.00 | $106,285.00 | $358,033.00 | $358,033.00 |
| Long Term Debt and Capital Lease Obligation | $355,557.00 | $355,557.00 | $106,285.00 | $358,033.00 | $358,033.00 |
| -Long Term Capital Lease Obligation | $355,557.00 | $355,557.00 | $106,285.00 | $358,033.00 | $358,033.00 |
| Total Equity | $5.18M | $5.18M | $357,972.00 | $49,243.00 | $49,243.00 |
| Stockholders' Equity | $5.18M | $5.18M | $357,972.00 | $49,243.00 | $49,243.00 |
| Capital Stock | $1,718.00 | $1,718.00 | $1,534.00 | $1,534.00 | $1,534.00 |
| -Common Stock | $1,718.00 | $1,718.00 | $1,534.00 | $1,534.00 | $1,534.00 |
| Additional Paid-In Capital | $5.10M | $5.10M | $312,880.00 | $312,880.00 | $312,880.00 |
| Minority Interests | – | – | $0.00 | – | – |
| Other Equity Interests | – | – | – | -$381,043.00 | -$381,043.00 |
Cash flow
| Line item | 2026 ANNUAL | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL |
|---|---|---|---|---|
| Free Cash Flow | -$1.56M | $138,361.00 | $84,831.00 | $1.83M |
| Effect of Exchange Rate Changes | -$14,708.00 | -$4,617.00 | -$10,513.00 | $5,657.00 |
| Beginning Cash Balance | $816,771.00 | $2.10M | $1.93M | $1.53M |
| Net Change in Cash | $3.90M | -$1.28M | $184,976.00 | $397,331.00 |
| Ending Cash Balance | $4.70M | $816,771.00 | $2.10M | $1.93M |
| Net Other Financing Charges | $5.53M | $472,374.00 | $215,996.00 | -$1.25M |
| Net Issuance Payments Of Debt | -$242,260.00 | $48,929.00 | -$115,851.00 | -$177,919.00 |
| Net Cash Flow from Continuing Financing Activities | $5.29M | $521,303.00 | $100,145.00 | -$1.43M |
| Financing Cash Flow | $5.29M | $521,303.00 | $100,145.00 | -$1.43M |
| Net Investment Purchase and Sale | $130,047.00 | -$1.94M | $0.00 | – |
| Net PPE Purchase and Sale | -$309,062.00 | -$287,527.00 | -$210,598.00 | -$606,194.00 |
| Net Cash Flow from Continuing Investing Activities | -$179,015.00 | -$2.23M | -$210,598.00 | -$606,194.00 |
| Net cash flow from investing | -$179,015.00 | -$2.23M | -$210,598.00 | -$606,194.00 |
| Net Income from Continuing Operations | -$22,648.00 | $1.20M | $821,743.00 | -$335,605.00 |
| Operating Cash Flow | -$1.22M | $425,888.00 | $295,429.00 | $2.43M |
| Net cash flow from continuing operations | -$1.22M | $425,888.00 | $295,429.00 | $2.43M |
| Gain/Loss from Continuing Operations | -$11,796.00 | – | – | – |
| Depreciation & Depletion & Amortization | $216,074.00 | $263,454.00 | $391,704.00 | $211,078.00 |
| Deferred Tax | $67,983.00 | $134,873.00 | $62,477.00 | – |
| Other Non-Cash Items | -$23,882.00 | -$8,266.00 | -$37,446.00 | $60,898.00 |
| Change in Working Capital | -$1.42M | -$1.16M | -$943,049.00 | $2.50M |
| -Change in Receivables | $194,424.00 | -$44,287.00 | -$164,976.00 | -$154,018.00 |
| -Change In Other Working Capital | -$415,869.00 | -$1.06M | -$1.11M | $2.64M |
| -Change in Payables and Accrued Expense | $254,867.00 | -$102,601.00 | $329,529.00 | $180,403.00 |
| -Change in Prepaid Assets | -$1.45M | $42,075.00 | -$39,266.00 | -$113,831.00 |
| -Change in Inventory | $1,174.00 | $1,354.00 | $38,181.00 | -$55,873.00 |
Income statement
| Line item | 2026 ANNUAL | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL |
|---|---|---|---|---|
| Non-Operating Interest Income | $72,651.00 | $64,136.00 | $19,513.00 | $10,288.00 |
| Other Income (Expense) | $85,487.00 | -$12,519.00 | -$214.00 | $19,312.00 |
| Gain on Sale of Security | $34,724.00 | $2,621.00 | – | – |
| Other Non-Operating Income (Expenses) | $50,763.00 | -$15,140.00 | -$214.00 | $19,312.00 |
| Pretax Profit | $133,466.00 | $1.44M | $1.00M | -$420,468.00 |
| Tax | $156,114.00 | $236,082.00 | $181,751.00 | -$84,863.00 |
| Net Profit | -$22,648.00 | $1.20M | $821,743.00 | -$335,605.00 |
| Profit from Continuing Operations | -$22,648.00 | $1.20M | $821,743.00 | -$335,605.00 |
| Minority Interests | $0.00 | $0.00 | $43,932.00 | -$30,488.00 |
| Net Income to Parent Company | -$22,648.00 | $1.20M | $777,811.00 | -$305,117.00 |
| Net Income to Common Stockholders | -$22,648.00 | $1.20M | $777,811.00 | -$305,117.00 |
| Basic EPS | $0.00 | $0.07 | $0.05 | -$0.02 |
| Diluted EPS | $0.00 | $0.07 | $0.05 | -$0.02 |
| Total Other Finance Costs | $137,746.00 | $210,688.00 | $163,710.00 | $142,311.00 |
| Non-Operating Interest Expense | $15,799.00 | $20,874.00 | $26,051.00 | $20,259.00 |
| Total Revenue as Reported | $4.81M | $6.22M | $6.02M | $3.53M |
| Total Operating Revenue | $4.81M | $6.22M | $6.02M | $3.53M |
| Cost of Revenue | $1.80M | $2.04M | $2.10M | $2.04M |
| Gross Profit | $3.01M | $4.18M | $3.91M | $1.49M |
| Operating Expense | $2.88M | $2.57M | $2.74M | $1.78M |
| Selling and Admin Expenses | $2.68M | $2.32M | $2.35M | $1.66M |
| -Selling & Marketing Expense | $803,483.00 | $999,354.00 | $859,473.00 | $664,882.00 |
| -General & Admin Expense | $1.88M | $1.32M | $1.49M | $996,947.00 |
| Net Non-Operating Interest Income (Expense) | -$80,894.00 | -$167,426.00 | -$170,248.00 | -$152,282.00 |
| Operating Profit | $128,873.00 | $1.62M | $1.17M | -$287,498.00 |
| Other Operating Expenses | -$20,364.00 | -$15,486.00 | -$1,398.00 | -$91,527.00 |
| -Depreciation & Amortization | $216,074.00 | $263,454.00 | $391,704.00 | $211,078.00 |
| Depreciation & Amortization & Depletion | $216,074.00 | $263,454.00 | $391,704.00 | $211,078.00 |
No comments yet — be the first to weigh in on MCTA.